From DCAT Value Chain Insights (VCI)
Aptuit has named Henning Steinhagen, PhD, as executive vice president, drug discovery and development, and site-head Verona. In this role, he will focus on the growth of Aptuit as a partner research organization and provider of outsourced services in the early discovery and development space. He joins Aptuit from Grünenthal, a global pharmaceutical company.
At Grünenthal, Dr. Steinhagen was senior vice president and head of global drug discovery. Before joining Grünenthal, Dr. Steinhagen served for seve years at Sanofi-Aventis in positions of increasing responsibility in medicinal chemistry. Before that he was in the medicinal chemistry group at Bayer.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription